475 Anti-TIGIT antibody tiragolumab leverages myeloid cells and regulatory T cells to improve PD-L1 checkpoint blockadeNamrata S. Patil, David S. Shames, Shyam Srivats et al.|Regular and Young Investigator Award Abstracts|2022Cited by 3
Abstract 5712: Anti-TIGIT antibody tiragolumab leverages myeloid cells and regulatory T cells to improve PD-L1 checkpoint blockadeNamrata S. Patil, David S. Shames, Shyam Srivats et al.|Cancer Research|2023Cited by 0